-
1
-
-
0001886508
-
Opioid analgesics and antagonists
-
Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. New York: McGraw-Hill
-
Riesine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996:535.
-
(1996)
Goodman & Gilman's the Pharmacological Basis of Therapeutics
, pp. 535
-
-
Riesine, T.1
Pasternak, G.2
-
2
-
-
0035088248
-
Hydromorphone: Pharmacology and clinical applications in cancer patients
-
Sarhill N, Walsh D, Nelson KA. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer. 2001;9:84-96.
-
(2001)
Support Care Cancer
, vol.9
, pp. 84-96
-
-
Sarhill, N.1
Walsh, D.2
Nelson, K.A.3
-
3
-
-
17644414461
-
Two double blind randomized trials of once-a-day controlled release oral hydromorphone (Palladone XL) compared to immediate release hydromorphone dosed QID
-
October 1999; Ft. Lauderdale, Fla. Abstract 645
-
Weinstein S, Lacouture PG, Grosser AB, et al. Two double blind randomized trials of once-a-day controlled release oral hydromorphone (Palladone XL) compared to immediate release hydromorphone dosed QID. Presented at: American Pain Society 18th annual meeting, October 1999; Ft. Lauderdale, Fla. Abstract 645.
-
American Pain Society 18th Annual Meeting
-
-
Weinstein, S.1
Lacouture, P.G.2
Grosser, A.B.3
-
4
-
-
0003484310
-
-
Bethesda, Md: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
-
Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Bethesda, Md: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 2001.
-
(2001)
Guidance for Industry: Bioanalytical Method Validation
-
-
-
6
-
-
0035699860
-
Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid® IR) in young and elderly subjects
-
Durnin C, Hind ID, Ghani SP, Yates DB, Cross M. Pharmacokinetics of oral immediate-release hydromorphone (Dilaudid® IR) in young and elderly subjects. Proc West Pharmacol Soc. 2001;44:79-80.
-
(2001)
Proc West Pharmacol Soc
, vol.44
, pp. 79-80
-
-
Durnin, C.1
Hind, I.D.2
Ghani, S.P.3
Yates, D.B.4
Cross, M.5
-
7
-
-
0035699648
-
Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR)
-
Durin C, Hind ID, Channon E, Yates DB, Cross M. Effect of food on the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR). Proc West Pharmacol Soc. 2001;44:75-76.
-
(2001)
Proc West Pharmacol Soc
, vol.44
, pp. 75-76
-
-
Durin, C.1
Hind, I.D.2
Channon, E.3
Yates, D.B.4
Cross, M.5
-
8
-
-
0035697768
-
Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR)
-
Durin C, Hind ID, Ghani SP, Yates DB, Cross M. Dose proportionality of the pharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR). Proc West Pharmacol Soc. 2001;44:73-74.
-
(2001)
Proc West Pharmacol Soc
, vol.44
, pp. 73-74
-
-
Durin, C.1
Hind, I.D.2
Ghani, S.P.3
Yates, D.B.4
Cross, M.5
-
9
-
-
0036792244
-
Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers
-
Drover DR, Angst MS, Valle M, et al. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. Anesthesiology. 2002;97:827-836.
-
(2002)
Anesthesiology
, vol.97
, pp. 827-836
-
-
Drover, D.R.1
Angst, M.S.2
Valle, M.3
|